Collectively, these results demonstrated that the anti-tumor activities of C118P against GC cells were attenuated following RAB1A knockdown, reflecting that C118P exerts its anti-tumor effects in GC cells via targeting RAB1A. The gene discussed is RAB1A; the disease is gastric cancer.